Alternative approaches, including RNA-based therapeutics targeting the most common ALS genes—SOD1, C9ORF72, FUS, and ATXN2—using small activating RNAs (saRNA) [22]. The gene discussed is SOD1; the disease is amyotrophic lateral sclerosis.